B
바이오스마트
038460KOSDAQ전자부품 제조업59.5 / 100
Reference Date: 2026-04-13
Financial Score24.0 / 40
News Sentiment12.5 / 25
Momentum13.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Declined 6.4% over the past month, and news sentiment is neutral.
Company InformationBased on 2025 Annual Report
Business Overview
BioSmart operates diverse business segments including smart card manufacturing, pharmaceuticals, alcohol payment solutions, heavy electrical equipment, and publishing, leveraging cross-industry synergies for sustainable growth. The heavy electrical/electrical products segment contributes the highest revenue share, followed by smart card and pharmaceutical businesses.
Number of Employees
168people
Average Salary
57.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
12.16Industry Average 21.846.5Point
Lower than industry avg (good)
PBR
0.60Industry Average 1.237.0Point
Half of industry avg (excellent)
ROE
5.22Industry Average 4.684.0Point
In line with industry avg
Debt Ratio
17.05Industry Average 10.870.5Point
1.6x industry avg (risky)
Trend 2023~20256.0 / 10 points
Revenue Growth Rate
1.0 / 3
Avg ▲2.9% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲56.1% (2-year basis)
ROE Trend
2.0 / 4
Avg ROE 7.0% (declining, 3yr)
Detailed News Sentiment
2 totalPositive 0Neutral 0Negative 0
- Neutral
- Neutral
Detailed Momentum
52-week position5.0Point
52w mid range (46%)
Current 4,330Won52-week high 6,25052-week low 2,670
1-month return2.0Point
1m -6.38% (slight drop)
Volume trend6.0Point
Volume increasing
Detailed Disclosure
6 totalPositive 0Neutral 6Negative 0
- Neutral주식등의대량보유상황보고서(약식)2026-04-09
- Neutral정기주주총회결과2026-03-27
- Neutral사외이사의선임ㆍ해임또는중도퇴임에관한신고2026-03-27
- Neutral감사보고서제출2026-03-19
- Neutral[기재정정]주식소각결정2026-03-19
